Marnie Preston, PhD

Marnie Preston, PhD has a wealth of experience in the research field. Marnie began their career in 2002 as an Undergraduate Research Assistant at the University of Texas at Austin, where they conducted behavioral analysis of neurological function following ischemic stroke and in rodent models of neurodegenerative disease, as well as histological analysis of cortical tissue for multiple research projects in the laboratory. In 2006, they moved to OHSU as a Graduate Research Assistant, where they tested the role of an extracellular matrix molecule, Hyaluronan, in oligodendrocyte progenitor cell (OPC) proliferation and maturation following demyelinating insults, developed a primary cell culture system for producing mouse OPCs, and characterized the expression of Hyaluronan degradation enzymes in OPC proliferation and maturation in vitro, and in a mouse models of demyelination. In 2011, they became a Postdoctoral Researcher at the University of Oregon, where they developed transgenic fish to assay motoneuron behavior in vivo with time-lapse microscopy and spinal cord genesis in D. rerio. In 2012, they moved to the University of Colorado Denver, Anshulz Medical Center, where they were a Postdoctoral Researcher, generating novel transgenic reporter fish to rapidly assay myelination in vivo. In 2014, they became an Biology Adjunct Instructor at Red Rocks Community College. In 2018, they joined InVivo Biosystems as a Principal Scientist, R&D, Genome Engineering Modalities, Director of Transgenics, Staff Scientist - Genome Editing, and Zebrafish Group Leader. Marnie is currently a Scientist R&D Genomics at InVivo Biosystems.

Marnie Preston, PhD completed their Doctor of Philosophy (PhD) in Neuroscience from Oregon Health & Science University between 2005 and 2011. Prior to that, they obtained their Bachelor's degree in Biology, Neurobiology Emphasis from The University of Texas at Austin between 1998 and 2004. Marnie also attended the University of Colorado Anschutz Medical Campus.